Testing effectiveness (Phase 2)Study completedNCT01435122What this trial is testingAxitinib in Advanced Carcinoid TumorsWho this might be right forCarcinoid Tumor H. Lee Moffitt Cancer Center and Research Institute 30
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Testing effectiveness (Phase 2)WithdrawnNCT04276597What this trial is testingPhase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.Who this might be right forPulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more Excel Diagnostics and Nuclear Oncology Center
Testing effectiveness (Phase 2)Study completedNCT05199584What this trial is testingA Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsWho this might be right forSolid Tumors With PTCH1 Loss-of-function Mutations Endeavor Biomedicines, Inc. 20
Not applicableEnded earlyNCT01271959What this trial is testingChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry StudyWho this might be right forSolid Organ Tumors Precision Therapeutics 167
Not applicableUnknownNCT00454376What this trial is testingDisease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more National Cancer Institute (NCI) 408
Testing effectiveness (Phase 2)UnknownNCT01175096What this trial is testingSafety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine TumorWho this might be right forNeuroendocrine TumorsCarcinoid Tumor Guangdong Provincial People's Hospital 20
Not applicableEnded earlyNCT00087191What this trial is testingEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerWho this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00580320What this trial is testingSafety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue SarcomaWho this might be right forMelanomaSoft Tissue SarcomaParathyroid Carcinoma+2 more Virginia Commonwealth University 17
Testing effectiveness (Phase 2)WithdrawnNCT04915144What this trial is testing177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETsWho this might be right forNeuroendocrine TumorsCarcinoid TumorPulmonary Carcinoid Tumor+4 more British Columbia Cancer Agency
Early research (Phase 1)Ended earlyNCT02875223What this trial is testingA Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's LymphomasWho this might be right forLymphoma, Non-HodgkinNeoplasms Celgene 75
Not applicableStudy completedNCT00303901What this trial is testingCryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By SurgeryWho this might be right forLung CancerMetastatic Cancer Barbara Ann Karmanos Cancer Institute 40
Not applicableEnded earlyNCT03707925What this trial is testingBronchoscopic Laser Ablation of Peripheral Lung TumorsWho this might be right forLung Carcinoid TumorLung Non-Small Cell CarcinomaMetastatic Lung Carcinoma+3 more M.D. Anderson Cancer Center 4
Not applicableActive Not RecruitingNCT03583528What this trial is testingDOTATOC PET/CT for Imaging NET PatientsWho this might be right forNeuroendocrine TumorsInsulinomaGastrinoma+13 more British Columbia Cancer Agency 800
Early research (Phase 1)Study completedNCT00655655What this trial is testingEverolimus and Vatalanib in Treating Patients With Advanced Solid TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+17 more Mayo Clinic 96
Testing effectiveness (Phase 2)Study completedNCT00027638What this trial is testingThalidomide in Treating Patients With Metastatic Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+1 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT03879694What this trial is testingSurvivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine TumorsWho this might be right forLung Atypical Carcinoid TumorLung Typical Carcinoid TumorMetastatic Pancreatic Neuroendocrine Tumor Roswell Park Cancer Institute 19
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00019331What this trial is testingVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsWho this might be right forColorectal CancerEndometrial CancerHead and Neck Cancer+6 more National Cancer Institute (NCI)